CEO of Fluofarma, Jean-Baptiste Pin has over 8 years experience in the
pharmaceutical and biotechnology industries in the areas of general management
and business development. Before joining Fluofarma, he was a Senior Consultant
at Ernst & Young specialized in Biotechnology.
Dr Mahfoudi has a strong background in drug discovery, preclinical and early clinical research gained from a 13 years experience in pharmaceutical field. He held several senior R&D and alliance management positions at Aventis pharmaceuticals (now Sanofi-aventis). Thereafter, he took business development, marketing and technology transfer assignement in several companies (Nautilus Biotech, Intergragen, Cerep, Guerbet and Inserm-Transfert).
Gaëlle is the director of Fluofarma laboratories and has a strong background in the field of High Throughput Screening. Before joining the company, she worked for the French biotechnology company Urogene.
Project manager at Fluofarma, Loïc plays a key role in managing relationship between our scientist team and our clients. He is also responsible for the supervision of Fluofarma European projects.
Marketing manager at Fluofarma, Julie is responsible for corporate communication, strategic watch and marketing intelligence. Before joining the company, she worked as Licensing Manager for CEA Valorisation, the technology transfer office of the French public R&D establishment CEA.
FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to
compare and profile your anti-cancer drugs. Read
more [+]